208 related articles for article (PubMed ID: 15183327)
1. Ligand identification for G-protein-coupled receptors: a lead generation perspective.
Bleicher KH; Green LG; Martin RE; Rogers-Evans M
Curr Opin Chem Biol; 2004 Jun; 8(3):287-96. PubMed ID: 15183327
[TBL] [Abstract][Full Text] [Related]
2. Development and virtual screening of target libraries.
Rognan D
J Physiol Paris; 2006; 99(2-3):232-44. PubMed ID: 16459061
[TBL] [Abstract][Full Text] [Related]
3. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ
Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
[TBL] [Abstract][Full Text] [Related]
5. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
Langer T; Krovat EM
Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
[TBL] [Abstract][Full Text] [Related]
6. Strategies for designing GPCR-focused libraries and screening sets.
Jimonet P; Jäger R
Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
[TBL] [Abstract][Full Text] [Related]
7. Modeling G protein-coupled receptors for structure-based drug discovery using low-frequency normal modes for refinement of homology models: application to H3 antagonists.
Rai BK; Tawa GJ; Katz AH; Humblet C
Proteins; 2010 Feb; 78(2):457-73. PubMed ID: 19787776
[TBL] [Abstract][Full Text] [Related]
8. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
9. The synergy between combinatorial chemistry and high-throughput screening.
Diller DJ
Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
[TBL] [Abstract][Full Text] [Related]
10. Design of a gene family screening library targeting G-protein coupled receptors.
Lamb ML; Bradley EK; Beaton G; Bondy SS; Castellino AJ; Gibbons PA; Suto MJ; Grootenhuis PD
J Mol Graph Model; 2004 Sep; 23(1):15-21. PubMed ID: 15331050
[TBL] [Abstract][Full Text] [Related]
11. Are target-family-privileged substructures truly privileged?
Schnur DM; Hermsmeier MA; Tebben AJ
J Med Chem; 2006 Mar; 49(6):2000-9. PubMed ID: 16539387
[TBL] [Abstract][Full Text] [Related]
12. New tools for G-protein coupled receptor (GPCR) drug discovery: combination of baculoviral expression system and solid state NMR.
Ratnala VR
Biotechnol Lett; 2006 Jun; 28(11):767-78. PubMed ID: 16786240
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
14. PREDICT modeling and in-silico screening for G-protein coupled receptors.
Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
[TBL] [Abstract][Full Text] [Related]
15. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
[TBL] [Abstract][Full Text] [Related]
16. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
17. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
[TBL] [Abstract][Full Text] [Related]
18. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
Tanrikulu Y; Schneider G
Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
[TBL] [Abstract][Full Text] [Related]
19. De novo drug design: integration of structure-based and ligand-based methods.
Dean PM; Lloyd DG; Todorov NP
Curr Opin Drug Discov Devel; 2004 May; 7(3):347-53. PubMed ID: 15216939
[TBL] [Abstract][Full Text] [Related]
20. The 7 TM G-protein-coupled receptor target family.
Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
